World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
92
Citations
35366
World Ranking
998
National Ranking
543

Medicine

D-Index
92
Citations
35366
World Ranking
11205
National Ranking
5758

Edward E. Walsh publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Edward E. Walsh sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 253 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Edward E. Walsh D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Edward E. Walsh sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 92 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Edward E. Walsh is affiliated with the University of Rochester Medical Center in the United States. Their research predominantly centers on medical sciences, with a significant focus on epidemiology and infectious diseases within the broader field of medicine.

The scientist's recent papers include the following:

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates, 2020, published in New England Journal of Medicine
  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, 2020, published in Nature
  • Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults, 2023, published in New England Journal of Medicine
  • SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3, 2021, published in New England Journal of Medicine
  • Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults, 2023, published in New England Journal of Medicine

Coauthors who have frequently collaborated with Edward E. Walsh include:

  • Ann R. Falsey
  • Angela R Branche
  • Thomas J. Mariani
  • Alejandra Gurtman
  • Kena A. Swanson

The scientist has published extensively in several venues. These include:

  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • New England Journal of Medicine
  • Clinical Infectious Diseases

Main fields of study covered by Edward E. Walsh are medicine, with subfields emphasizing epidemiology, infectious diseases, pulmonary and respiratory medicine, cardiology and cardiovascular medicine, and surgery.

The primary topics addressed in their research encompass:

  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 research
  • Pneumonia and respiratory infections
  • Viral gastroenteritis research and epidemiology
  • Neonatal respiratory health research
  • Tracheal and airway disorders
  • Congenital diaphragmatic hernia studies

Best Publications

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • Respiratory syncytial virus infection in elderly and high-risk adults.

    Ann R. Falsey;Patricia A. Hennessey;Maria A. Formica;Christopher Cox

  • Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

    Evelyn A. Kurt-Jones;Lana Popova;Laura Kwinn;Lia M. Haynes

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • Immunity to and Frequency of Reinfection with Respiratory Syncytial Virus

    Caroline Breese Hall;Edward E. Walsh;Christine E. Long;Kenneth C. Schnabel

  • Respiratory Syncytial Virus Infection in Adults

    Ann R. Falsey;Edward E. Walsh

  • Human Metapneumovirus Infections in Young and Elderly Adults

    Ann R Falsey;Dean Erdman;Larry J Anderson;Edward E Walsh

  • Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

    Hall Cb;McBride Jt;Walsh Ee;Bell Dm

  • Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.

    Unknown

  • Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

    Jessica L. Halliley;Jessica L. Halliley;Christopher M. Tipton;Jane Liesveld;Alexander F. Rosenberg

  • A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

    John DeVincenzo;Robert Lambkin-Williams;Tom Wilkinson;Jeffrey Cehelsky

  • Occurrence of Groups A and B of Respiratory Syncytial Virus over 15 Years: Associated Epidemiologic and Clinical Characteristics in Hospitalized and Ambulatory Children

    Caroline Breese Hall;Edward E. Walsh;Kenneth C. Schnabel;Christine E. Long

  • The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

    Natalie I Mazur;Deborah Higgins;Marta C Nunes;José A Melero

  • Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus.

    G A Prince;A B Jenson;V G Hemming;B R Murphy

  • Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.

    B R Murphy;G A Prince;E E Walsh;H W Kim

  • Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.

    E E Walsh;J Hruska

  • Protection of Mice Against Dengue 2 Virus Encephalitis by Immunization with the Dengue 2 Virus Non-structural Glycoprotein NS1

    Jacob J. Schlesinger;Michael W. Brandriss;Edward E. Walsh

  • Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.

    P R Johnson;R A Olmsted;G A Prince;B R Murphy

  • SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.

    Ann R Falsey;Robert W Frenck;Edward E Walsh;Nicholas Kitchin

  • Severity of Respiratory Syncytial Virus Infection Is Related to Virus Strain

    Edward E. Walsh;Kenneth M. McConnochie;Christine E. Long;Caroline B. Hall

  • Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.

    Sara M. Johnson;Sara M. Johnson;Beth A. McNally;Beth A. McNally;Ioannis Ioannidis;Ioannis Ioannidis;Emilio Flano;Emilio Flano

  • Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.

    J J Schlesinger;M W Brandriss;E E Walsh

Frequent Co-Authors

Ann R. Falsey
Ann R. Falsey University of Rochester
David J. Topham
David J. Topham University of Rochester Medical Center
Caroline B. Hall
Caroline B. Hall University of Rochester
Steven R. Gill
Steven R. Gill University of Rochester Medical Center
Janet A. Englund
Janet A. Englund Seattle Children's Hospital
Philip R. Dormitzer
Philip R. Dormitzer Pfizer (United States)
Larry J. Anderson
Larry J. Anderson Emory University
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Kathrin U. Jansen
Kathrin U. Jansen Pfizer (United States)
David A. Cooper
David A. Cooper University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students find enrolling in easiest absn program to get into helpful when transitioning into nursing, combining accelerated paths with foundational medical knowledge.

Similarly, starting with the best easiest lpn programs to get into offers a gateway into patient care, fostering essential clinical skills that complement immunological studies.

Advancing further, many pursue advanced practice roles through nurse practitioner programs with easy admission, which integrate clinical expertise with leadership in healthcare settings.

For those focusing on mental health and immunology's intersection, enrolling in the top online pmhnp programs can provide excellent clinical placements and specialized training.

These pathways emphasize flexible online options with streamlined admissions and strong practical training, making them accessible for students aiming to enhance their credentials in immunology-related healthcare careers.

Best Scientists Citing Edward E. Walsh

Trending Scientists

Recently Published Articles